These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. New drug approvals in 2000. Wynn RL Gen Dent; 2001; 49(4):341-5. PubMed ID: 12016673 [No Abstract] [Full Text] [Related]
6. Exit Exubera. Inhalable insulin is withdrawn due to weak sales. Keegan A Diabetes Forecast; 2007 Dec; 60(13):19. PubMed ID: 18217270 [No Abstract] [Full Text] [Related]
7. Can the U.S. Food and Drug Administration act against global frauds? The extraterritorial effect of Food and Drug Administration sanctions after Small v. United States. O'Reilly J Food Drug Law J; 2005; 60(3):347-60. PubMed ID: 16304742 [No Abstract] [Full Text] [Related]
8. Removal of regulations regarding certification of drugs composed wholly or partly of insulin; companion document to direct final rule--FDA. Proposed rule. Fed Regist; 1998 May; 63(92):26690-3. PubMed ID: 10179340 [TBL] [Abstract][Full Text] [Related]
9. Food and Drug Administration approval of a fifth acellular pertussis vaccine for use among infants and young children--United States, 2002. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2002 Jul; 51(26):574. PubMed ID: 12139185 [TBL] [Abstract][Full Text] [Related]
10. Technologies that deliver. Basu P Nat Med; 2003 Sep; 9(9):1100-1. PubMed ID: 12949511 [No Abstract] [Full Text] [Related]
11. The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval process. Roden DM; Temple R Circulation; 2005 Apr; 111(13):1697-702. PubMed ID: 15811869 [No Abstract] [Full Text] [Related]
13. FDA reform in Congress: interview with Peter Barton Hutt. Food and Drug Administration. Interview by John S. James. Hutt PB AIDS Treat News; 1996 Apr; (no 245):4-5. PubMed ID: 11363623 [TBL] [Abstract][Full Text] [Related]
14. The approval process for hyperthermic intraoperative intraperitoneal chemotherapy. Sugarbaker PH; Clarke L Eur J Surg Oncol; 2006 Aug; 32(6):637-43. PubMed ID: 16630703 [TBL] [Abstract][Full Text] [Related]
15. United States Food and Drug Administration requirements for approval of generic drug products. Meyer MC J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846 [TBL] [Abstract][Full Text] [Related]
16. FDA looks at full approval for d4T. Food and Drug Administration. Posit Aware; 1996; 7(1):7. PubMed ID: 11363131 [TBL] [Abstract][Full Text] [Related]
17. The United States Food and Drug Administration and the end of antibiotics. Shlaes DM; Moellering RC Clin Infect Dis; 2002 Feb; 34(3):420-2. PubMed ID: 11774094 [No Abstract] [Full Text] [Related]
18. Food and Drug Administration grants approval for 131I MIBG. Miller L J Nucl Med; 1994 Jun; 35(6):13N, 17N. PubMed ID: 8195874 [No Abstract] [Full Text] [Related]
19. Food and Drug Administration approval process for ophthalmic drugs in the US. Lloyd R; Harris J; Wadhwa S; Chambers W Curr Opin Ophthalmol; 2008 May; 19(3):190-4. PubMed ID: 18408492 [TBL] [Abstract][Full Text] [Related]
20. FDA shortened drug approval time in 1995. Public Health Rep; 1996; 111(4):290. PubMed ID: 8711090 [No Abstract] [Full Text] [Related] [Next] [New Search]